Literature DB >> 19965617

Mouse hepatic lipase alleles with variable effects on lipoprotein composition and size.

Serena M Pratt1, Sally Chiu, Glenda M Espinal, Noreene M Shibata, Howard Wong, Craig H Warden.   

Abstract

The structural features responsible for the activities of hepatic lipase (HL) can be clarified by in vivo comparisons of naturally occurring variants. The coding sequence of HL from C57BL/6J (B6) and SPRET/EiJ (SPRET) mice differs by four amino acids (S106N, A156V, L416V, S480T); however, these changes are not predicted to influence HL function. To test for allelic effects, we generated SPRET-HL transgenics with physiological levels of HL mRNA and HL activity that was parallel in female transgenics and about 70% higher in male transgenics, toward tri-[3H]oleate, compared with B6 controls. We found no correlation between activity levels and plasma lipids. However, significant allelic effects on plasma lipids were observed. Compared with B6-HL, SPRET-HL mediated reductions in total cholesterol (TC) and VLDL-, LDL- and HDL-cholesterol and HDL-triglyceride (TG) in fed males, and SPRET-HL decreased total TG and VLDL- and HDL-TG levels in fasted males. Fasted female transgenics had reduced TC compared with controls. We also found allele and sex effects on lipoprotein particle size. Male transgenic mice had increased VLDL and decreased LDL size, and female transgenic mice had decreased HDL size compared with control animals. These findings demonstrate highly divergent effects of naturally occurring HL coding sequence variants on lipid and lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19965617      PMCID: PMC2853430          DOI: 10.1194/jlr.M002378

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  58 in total

1.  Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene.

Authors:  P Knudsen; M Antikainen; M Uusi-Oukari; S Ehnholm; S Lahdenperä; A Bensadoun; H Funke; H Wiebusch; G Assmann; M R Taskinen; C Ehnholm
Journal:  Atherosclerosis       Date:  1997-02-10       Impact factor: 5.162

2.  Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP).

Authors:  A Krapp; S Ahle; S Kersting; Y Hua; K Kneser; M Nielsen; J Gliemann; U Beisiegel
Journal:  J Lipid Res       Date:  1996-05       Impact factor: 5.922

3.  Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia.

Authors:  K A Dugi; I M Feuerstein; S Hill; J Shih; S Santamarina-Fojo; H B Brewer; J M Hoeg
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-02       Impact factor: 8.311

4.  Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects.

Authors:  T D Watson; M J Caslake; D J Freeman; B A Griffin; J Hinnie; C J Packard; J Shepherd
Journal:  Arterioscler Thromb       Date:  1994-06

5.  Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver.

Authors:  E de Faria; L G Fong; M Komaromy; A D Cooper
Journal:  J Lipid Res       Date:  1996-01       Impact factor: 5.922

Review 6.  Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins.

Authors:  A Zambon; S Bertocco; N Vitturi; V Polentarutti; D Vianello; G Crepaldi
Journal:  Biochem Soc Trans       Date:  2003-10       Impact factor: 5.407

7.  Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene.

Authors:  G E Homanics; H V de Silva; J Osada; S H Zhang; H Wong; J Borensztajn; N Maeda
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

8.  Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women.

Authors:  C E Tan; L Foster; M J Caslake; D Bedford; T D Watson; M McConnell; C J Packard; J Shepherd
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311

9.  Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate.

Authors:  E A Brinton
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-03       Impact factor: 8.311

10.  A compound heterozygote for hepatic lipase gene mutations Leu334-->Phe and Thr383-->Met: correlation between hepatic lipase activity and phenotypic expression.

Authors:  P Knudsen; M Antikainen; S Ehnholm; M Uusi-Oukari; H Tenkanen; S Lahdenperä; J Kahri; M Tilly-Kiesi; A Bensadoun; M R Taskinen; C Ehnholm
Journal:  J Lipid Res       Date:  1996-04       Impact factor: 5.922

View more
  2 in total

1.  Mechanism of hypertriglyceridemia in CTP:phosphoethanolamine cytidylyltransferase-deficient mice.

Authors:  Ratnesh Kumar Singh; Morgan D Fullerton; Donna Vine; Marica Bakovic
Journal:  J Lipid Res       Date:  2012-07-04       Impact factor: 5.922

2.  A computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolism.

Authors:  Fianne L P Sips; Christian A Tiemann; Maaike H Oosterveer; Albert K Groen; Peter A J Hilbers; Natal A W van Riel
Journal:  PLoS Comput Biol       Date:  2014-05-01       Impact factor: 4.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.